Earnings Impact: Social media chatter intensified following UiPath's latest quarterly report, where the company missed revenue expectations yet delivered stronger-than-anticipated guidance for the coming periods. Observers noted that shares dipped in after-hours trading but highlighted the potential for recovery as forward-looking metrics showed resilience.
Technical Setup: Discussions also centered on chart patterns, with many pointing to a clean breakout above key resistance levels near $13 as a signal of renewed buying interest. Participants observed improving momentum indicators and higher trading volumes that could support further upside if the stock sustains these gains.
Fundamental Outlook: Broader commentary praised ongoing revenue growth and the company's first-ever GAAP profit in the quarter, underscoring a strengthening business amid sector rebounds. Sentiment across platforms remained mixed amid the earnings volatility but leaned cautiously optimistic on long-term positioning.
Note: This discussion summary was generated from an AI condensation of post data.
UiPath Insider Trading Activity
UiPath insiders have traded $PATH stock on the open market 33 times in the past 6 months. Of those trades, 0 have been purchases and 33 have been sales.
Here’s a breakdown of recent trading of $PATH stock by insiders over the last 6 months:
- DANIEL DINES (CEO and Chairman) has made 0 purchases and 31 sales selling 1,395,000 shares for an estimated $23,418,049.
- ASHIM GUPTA (COO & CFO) sold 67,468 shares for an estimated $1,086,497
- BRAD BRUBAKER (GC & Chief Legal Officer) sold 27,580 shares for an estimated $511,735
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
UiPath Revenue
UiPath had revenues of $418.4M in Q1 2027. This is an increase of 17.32% from the same period in the prior year.
You can track PATH financials on Quiver Quantitative's PATH stock page.
You can access data on PATH stock through the Quiver Quantitative API.
UiPath Hedge Fund Activity
We have seen 312 institutional investors add shares of UiPath stock to their portfolio, and 317 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TETRAGON PARTNERS GP LTD added 7,757,628 shares (+44.5%) to their portfolio in Q1 2026, for an estimated $85,024,378
- VOLORIDGE INVESTMENT MANAGEMENT, LLC removed 5,771,582 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $94,596,228
- JANE STREET GROUP, LLC added 5,562,246 shares (+1029.3%) to their portfolio in Q1 2026, for an estimated $60,962,772
- POINT72 ASSET MANAGEMENT, L.P. removed 5,453,002 shares (-73.7%) from their portfolio in Q1 2026, for an estimated $59,765,447
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 4,948,763 shares (-92.5%) from their portfolio in Q1 2026, for an estimated $54,238,937
- UBS GROUP AG added 4,633,195 shares (+97.1%) to their portfolio in Q1 2026, for an estimated $50,780,280
- CAPITAL IMPACT ADVISORS, LLC added 3,188,606 shares (+inf%) to their portfolio in Q4 2025, for an estimated $52,261,252
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
UiPath Price Targets
Multiple analysts have issued price targets for $PATH recently. We have seen 14 analysts offer price targets for $PATH in the last 6 months, with a median target of $13.0.
Here are some recent targets:
- Keith Bachman from BMO Capital set a target price of $13.0 on 06/01/2026
- Sanjit Singh from Morgan Stanley set a target price of $15.0 on 05/29/2026
- Brad Sills from B of A Securities set a target price of $13.0 on 05/29/2026
- Lucky Schreiner from DA Davidson set a target price of $12.0 on 05/29/2026
- Scott Berg from Needham set a target price of $15.0 on 05/29/2026
- Radi Sultan from UBS set a target price of $13.0 on 03/12/2026
- Terry Tillman from Truist Securities set a target price of $12.0 on 03/12/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
